Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H48O2 |
| Molecular Weight | 428.6902 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C3/C[C@@H](O)C[C@H](O)C3=C)C(C)C
InChI
InChIKey=NWFOBODUYTUMNC-VPSCEVSQSA-N
InChI=1S/C29H48O2/c1-7-22(19(2)3)11-10-20(4)26-14-15-27-23(9-8-16-29(26,27)6)12-13-24-17-25(30)18-28(31)21(24)5/h12-13,19-20,22,25-28,30-31H,5,7-11,14-18H2,1-4,6H3/b23-12+,24-13-/t20-,22-,25-,26-,27+,28+,29-/m1/s1
1α-HYDROXYVITAMIN D5 (CARD-024) is non-hypercalcemic, selective vitamin D receptor agonist under development for the treatment of cardiovascular disease, secondary hyperparathyroidism in chronic kidney disease and intestinal bowel disease fibrosis. CARD-024 attenuated the pro-fibrotic response of colonic myofibroblasts to high matrix stiffness, suggesting that it may ameliorate intestinal fibrosis.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| CARD-024, a vitamin D analog, attenuates the pro-fibrotic response to substrate stiffness in colonic myofibroblasts. | 2012-08 |
|
| Regulation of steroid receptor expression by 1alpha-hydroxyvitamin D5 in hormone-responsive breast cancer cells. | 2009-09 |
|
| Effect of vitamin D analog (1alpha hydroxy D5) immunoconjugated to Her-2 antibody on breast cancer. | 2004-03-01 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01757860
Healthy Subjects: oral administered: 3, 9, 27 or 81 ug.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22542712
To determine whether CARD-024 represses fibrogenesis in colonic myofibroblasts, Ccd-18co cells were stimulated with TGFβ and treated with 10 – 1000 nM CARD-024. In colonic myofibroblasts stimulated with TGFβ, increasing doses of CARD-024 attenuated αSMA protein expression in a dose-responsive manner. At the highest dose (1000 nM) CARD-024 attenuated αSMA protein expression 2-fold (p = 0.012)
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
XY02042OD4
Created by
admin on Mon Mar 31 18:27:19 GMT 2025 , Edited by admin on Mon Mar 31 18:27:19 GMT 2025
|
PRIMARY | |||
|
DTXSID501315324
Created by
admin on Mon Mar 31 18:27:19 GMT 2025 , Edited by admin on Mon Mar 31 18:27:19 GMT 2025
|
PRIMARY | |||
|
187935-17-7
Created by
admin on Mon Mar 31 18:27:19 GMT 2025 , Edited by admin on Mon Mar 31 18:27:19 GMT 2025
|
PRIMARY | |||
|
10025615
Created by
admin on Mon Mar 31 18:27:19 GMT 2025 , Edited by admin on Mon Mar 31 18:27:19 GMT 2025
|
PRIMARY | |||
|
DB13097
Created by
admin on Mon Mar 31 18:27:19 GMT 2025 , Edited by admin on Mon Mar 31 18:27:19 GMT 2025
|
PRIMARY |
ACTIVE MOIETY